ConductScience.org, home

Paper39192518

Myosteatosis and muscle loss impact liver transplant outcomes in male patients with hepatocellular carcinoma.

Lu D and 14 others. J Cachexia Sarcopenia Muscle, 2024. Cited by 24 papers, by iCite.

Cite this record

ConductScience Library. Myosteatosis and muscle loss impact liver transplant outcomes in male patients with hepatocellular carcinoma. Papers, record 39192518. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39192518

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Myosteatosis and muscle loss impact liver transplant outcomes in male patients with hepatocellular carcinoma.
PubMed
Journal
J Cachexia Sarcopenia Muscle
PubMed
Year
2024
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
24
iCite
Relative citation ratio, by iCite
4.31, provisional
iCite
Revised in PubMed
2026-06-28
PubMed

Authors15

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lu DDi
2Hu ZZhihang
3Chen HHao
4Khan AAAbid Ali
5Xu QQingguo
6Lin ZZuyuan
7Li HHuigang
8Zhuo JJianyong
9He CChiyu
10Zhuang LLi
11Yang ZZhe
12Dong SSiyi
13Cai JJinzhen
14Zheng SShusen
15Xu XXiaohttps://orcid.org/0000-0002-2761-2811

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Liver TransplantationMajor topic
Carcinoma, HepatocellularMajor topic
Liver NeoplasmsMajor topic
SarcopeniaMajor topic
Humans
Male
Middle Aged
Prognosis
Muscle, Skeletal
Female
Treatment Outcome
Tomography, X-Ray Computed

Source PubMed

Download CSV of topics

Grants6

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
92159202Major Research Plan of the National Natural Science Foundation of ChinaPubMed
2021YFA1100500National Key Research and Development Program of ChinaPubMed
81930016Key Program, National Natural Science Foundation of ChinaPubMed
82000617Young Program of National Natural Science FundsPubMed
2017ZX10203205National S&T Major ProjectPubMed
LQ23H160048Natural Science Foundation of Zhejiang ProvincePubMed

Source PubMed

Download CSV of grants

References38

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132217938Liver Transplantation for Hepatocellular Carcinoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference.Transplantation2020https://conductscience.org/library/papers/32217938PubMed
225804634Liver transplantation for hepatocellular carcinoma beyond the Milan criteria.Gut2016https://conductscience.org/library/papers/25804634PubMed
335395556Assessing dynamic change in muscle during treatment of patients with cancer: Precision testing standards.Clin Nutr2022https://conductscience.org/library/papers/35395556PubMed
435027442Sarcopenia: early prevention or overdiagnosis?BMJ2022https://conductscience.org/library/papers/35027442PubMed
535006438Cancer metabolism and intervention therapy.Mol Biomed2021https://conductscience.org/library/papers/35006438PubMed
637031334Development of a deep pathomics score for predicting hepatocellular carcinoma recurrence after liver transplantation.Hepatol Int2023https://conductscience.org/library/papers/37031334PubMed
736065509The effect of computed tomography parameters on sarcopenia and myosteatosis assessment: a scoping review.J Cachexia Sarcopenia Muscle2022https://conductscience.org/library/papers/36065509PubMed
835248726Clinical characteristics and survival analysis of liver transplantation in patients with alcoholic liver disease: A single-center retrospective study.Transpl Immunol2022https://conductscience.org/library/papers/35248726PubMed
928053342Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches.Nat Rev Gastroenterol Hepatol2017https://conductscience.org/library/papers/28053342PubMed
1029345251Cancer-associated cachexia.Nat Rev Dis Primers2018https://conductscience.org/library/papers/29345251PubMed
118594428Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.N Engl J Med1996https://conductscience.org/library/papers/8594428PubMed
1229970408Predicted lean body mass, fat mass, and all cause and cause specific mortality in men: prospective US cohort study.BMJ2018https://conductscience.org/library/papers/29970408PubMed
1329318756Loss of skeletal muscle during systemic chemotherapy is prognostic of poor survival in patients with foregut cancer.J Cachexia Sarcopenia Muscle2018https://conductscience.org/library/papers/29318756PubMed
1436417796Multi-omics profiling reveals Chitinase-3-like protein 1 as a key mediator in the crosstalk between sarcopenia and liver cancer.Redox Biol2022https://conductscience.org/library/papers/36417796PubMed
1535794004Sarcopenia Determined by Skeletal Muscle Index Predicts Overall Survival, Disease-free Survival, and Postoperative Complications in Resectable Esophageal Cancer: A Systematic Review and Meta-analysis.Ann Surg2022https://conductscience.org/library/papers/35794004PubMed
1639192518Myosteatosis and muscle loss impact liver transplant outcomes in male patients with hepatocellular carcinoma.J Cachexia Sarcopenia Muscle2024https://conductscience.org/library/papers/39192518PubMed
1735667542Experience with solid organ transplantation in patients with previous immunotherapy treatment is still limited but this is changing: The survey-based view of the global transplant society.Transpl Immunol2022https://conductscience.org/library/papers/35667542PubMed
1831448486Myosteatosis to predict inferior perioperative outcome in patients undergoing orthotopic liver transplantation.Am J Transplant2020https://conductscience.org/library/papers/31448486PubMed
1935068076Predicted fat mass and lean mass in relation to all-cause and cause-specific mortality.J Cachexia Sarcopenia Muscle2022https://conductscience.org/library/papers/35068076PubMed
2036994237Metabolic reprogramming in cancer: Mechanisms and therapeutics.MedComm (2020)2023https://conductscience.org/library/papers/36994237PubMed

See all 38 referencesDownload CSV of references

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.

PMIDTitleJournalYearIn PapersSource
42942575Longitudinal Changes in CT-Derived Vertebral Trabecular Attenuation and Psoas Muscle Density After Liver Transplantation for Hepatocellular Carcinoma.Medicina (Kaunas)2026https://conductscience.org/library/papers/42942575PubMed
42682768
The association between sarcopenia and the prognosis of patients with high tumor burden hepatocellular carcinoma receiving hepatic artery infusion chemotherapy combined with lenvatinib and programmed death receptor-1 inhibitor: a multicenter, propensity score matching comparative study.
Front Immunol2026https://conductscience.org/library/papers/42682768PubMed
42241922Prognostic role of myosteatosis in predicting MACE and mortality after TAVR: insights from CT-based body composition analysis.J Nutr Health Aging2026https://conductscience.org/library/papers/42241922PubMed
42122044Longitudinal CT-Based Assessment of Muscle and Bone Changes After Liver Transplantation in Hepatitis B Patients with and Without Hepatocellular Carcinoma.Diagnostics (Basel)2026https://conductscience.org/library/papers/42122044PubMed
42015025The impact of low skeletal muscle index and low muscle radiodensity on the prognosis of esophageal squamous cell carcinoma: a multi-center retrospective study in China (TIMES Study).BMC Cancer2026https://conductscience.org/library/papers/42015025PubMed
41400751Myosteatosis: Epidemiological Insights, Functional Decline, and Diagnostic Advances.Curr Obes Rep2025https://conductscience.org/library/papers/41400751PubMed
41278358Low Cystatin C-to-Creatinine Estimated GFR Ratio Predicts Post-Kidney Transplant Cardiovascular Events.Kidney Int Rep2025https://conductscience.org/library/papers/41278358PubMed
41211064Sarcopenia in liver transplantation: A comprehensive bibliometric study of current research trends and future directions.Open Life Sci2025https://conductscience.org/library/papers/41211064PubMed
41044458Changes in nutritional status in hepatocellular carcinoma patients treated with sorafenib.Support Care Cancer2025https://conductscience.org/library/papers/41044458PubMed
40892254Impact of body composition on prognostic stratification and survival in periampullary carcinoma after pancreatoduodenectomy.Abdom Radiol (NY)2026https://conductscience.org/library/papers/40892254PubMed
40647511Perioperative and Oncological Outcome in Patients Undergoing Curative-Intent Liver Resection for Cholangiocarcinoma in the Context of Osteopenia.Cancers (Basel)2025https://conductscience.org/library/papers/40647511PubMed
40489025Impact of myosteatosis on outcomes after liver transplantation: a systematic review and meta-analysis.Hepatol Int2025https://conductscience.org/library/papers/40489025PubMed
40377729Myosteatosis and the survival of patients with hepatocellular carcinoma: a meta-analysis.Clin Exp Med2025https://conductscience.org/library/papers/40377729PubMed
40308633Prognostic impact of body composition in hepatocellular carcinoma patients undergoing interventional and systemic therapy.Front Nutr2025https://conductscience.org/library/papers/40308633PubMed
40083684Molecular Mechanisms of Ischemia/Reperfusion Injury and Graft Dysfunction in Liver Transplantation: Insights from Multi-Omics Studies in Rodent Animal Models.Int J Biol Sci2025https://conductscience.org/library/papers/40083684PubMed
40042010Comment on "Myosteatosis and Muscle Loss Impact Liver Transplant Outcomes in Male Patients With Hepatocellular Carcinoma" by Lu et al.-The Authors' Reply.J Cachexia Sarcopenia Muscle2025https://conductscience.org/library/papers/40042010PubMed
39428603Comment on 'Myosteatosis and Muscle Loss Impact Liver Transplant Outcomes in Male Patients With Hepatocellular Carcinoma' by Lu et al.J Cachexia Sarcopenia Muscle2024https://conductscience.org/library/papers/39428603PubMed
39192518Myosteatosis and muscle loss impact liver transplant outcomes in male patients with hepatocellular carcinoma.J Cachexia Sarcopenia Muscle2024https://conductscience.org/library/papers/39192518PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39192518

GET https://conductscience.org/api/papers/v1/39192518/references?page=2